Gate News Bot news, on September 19, according to CoinMarketCap data, as of the time of writing, BIO (Bio Protocol) is currently priced at $0.17, with a rise of 6.18% in the last 24 hours, reaching a high of $0.19 and a low of $0.15. The 24-hour volume has reached $143 million. The current market capitalization is approximately $290 million, an increase of $16.9 million compared to yesterday. Bio Protocol is a new financial layer of DeSci (decentralized science) aimed at accelerating the commercialization of the best scientific results. The protocol allows anyone to fund, develop, and manage tokenized scientific innovations from universities, companies, and researchers around the world. The Bio ecosystem is driving biotechnological innovation by guiding funds and talent towards the most promising early scientific projects through decentralized financing and coordination. B

Paul Kohlhaas, the founder of Bio Protocol, stated that since the launch of AUBRAI, it has generated $180,000 in fees and over $20 million in volume in just 8 days. In the future, the aubr.ai terminal will be launched to support the minting of IP-NFTs and initiate RMR2 research. He collaborates with top scientists globally to support the success of DeSci builders and DAO, with the goal of achieving complete autonomous operation for Aubrai.

Gate News Bot news, on September 5th, according to CoinMarketCap data, as of the time of writing, BIO (Bio Protocol) is currently priced at $0.14, with a rise of 7.92% in the last 24 hours, reaching a high of $0.18 and a low of $0.13. The current market capitalization is approximately $239 million, an increase of $17.5 million compared to yesterday. Bio Protocol is a new financial layer of DeSci (decentralized science) aimed at accelerating the commercialization of optimal science. The protocol allows anyone to fund, develop, and manage tokenized scientific innovations from universities, companies, and researchers around the world. The goal of Bio Protocol is to promote biotechnology innovation through decentralized funding and coordination, directing capital and talent to the most promising early-stage scientific projects. Important news about BIO recently: 1️

The yesnoerror agent of DeSci AI has entered public testing, utilizing the AI models supported by the YNE Token to review over 500 new papers daily. Users can browse popular research, obtain detailed analyses, and filter options. Future plans include cross-chain to Base and expanding the audit scope.

PANews August 22 news, according to official news from the DeSci project Transfidelity, the project raised 76 ETH from 41 contributors to develop compounds that improve the accuracy of protein translation, in order to prevent neurodegenerative diseases caused by protein misfolding and aggregation. The support of Cerebrum DAO and Molecule DAO helped establish connections with the community focused on preventive research. The project party announced that it will launch the FIDEL Token next week to further promote related research and application development.

BlockBeats news, on August 22, according to HTX market data, BIO briefly touched 0.21 USD, currently quoted at 0.2035 USD, with a 24-hour rise of over 37%. The DeSci protocol Bio Protocol recently launched a token launch platform, with the first project being Aubrai. Users can obtain issuance allocation by staking BioXP, and investing in BIO allows them to receive tokens, with the final allocation depending on the staked BioXP share. The sales time for the first BioAgent Launch project Aubrai will last for 24

PANews August 21 news, according to TK Research analysis, $BIO Token is steadily rising in the DeSci field, with the current total Lock-up Position (TVL) of the Bio Protocol being approximately 9 million USD. Among this, about 70% is short-term lock-up (1 to 4 weeks), about 30% is medium to long-term lock-up, and 15.1% is locked for the longest period of 104 weeks. Analysis suggests that the continuous rise of the medium to long-term Lock-up Position ratio may drive up the Token price, while the high proportion of short-term positions may bring certain selling pressure. If the medium to long-term Lock-up Position ratio further increases, $BIO may welcome a new round of price rise.

Gate News Bot news, on August 21, according to CoinMarketCap data, as of the time of writing, BIO (Bio Protocol) is currently priced at 0.15 USD, with a rise of 22.44% in the last 24 hours, reaching a high of 0.17 USD and a low of 0.10 USD. The current market capitalization is approximately 250 million USD, an increase of 45.8 million USD compared to yesterday. Bio Protocol is a new financial layer for DeSci (decentralized science) aimed at accelerating the commercialization of the best scientific achievements. The protocol allows anyone to fund, develop, and manage tokenized scientific innovations from universities, companies, and researchers around the world. The Bio ecosystem is driving a series of decentralized science projects focused on specific therapeutic areas, including longevity research, women's health, psychopharmacology, synthetic biology, and more. Recent important news about BIO

BlockBeats news, on August 21, the DeSci protocol Bio Protocol announced the launch of its first BioAgent Launch project Aubrai, with sales lasting for 24 hours. During this period, users can stake BioXP and invest in BIO tokens to participate. AUBRAI tokens will be immediately available for market trading after the sale ends, and the project launch time will be announced later. According to HTX market information, possibly influenced by the recent increase in use cases, BIO briefly surpassed $0.17 today, currently priced at $0.1421, with a 24-hour rise of 9%.

Gate News bot news, according to the official announcement from Gate on August 18, 2025: Gate exchange announced the delisting of 27 tokens including 88MPH, ALTAIR, MATRIX and their corresponding USDT trading pairs. The exchange stated that these tokens have been assessed and do not meet the platform's listing standards. For users holding these tokens and who have submitted the relevant forms, Gate has completed the asset buyback and deposited the buyback amount into the users' accounts. The recharge and trading services for the relevant tokens have been suspended, and the withdrawal service will also be closed soon. The tokens involved in the delisting include: 88MPH, ALTAIR, MATRIX, MUNITY, BYIN, FRBK, EARLY, ROCO, HIT, RUFF, CATTON, SMILEAI, LANDWOLF, DMCK, NALS, DESCI, BTCS, NFTL, SPAY, KILT, CLH, CIRUS, DFI, BTF, FCON, CLAY, and VRTX.

Gate News Bot news, on August 18, according to CoinMarketCap data, as of the time of writing, BIO (Bio Protocol) is currently priced at $0.13, with a rise of 31.53% in the last 24 hours, reaching a high of $0.15 and a low of $0.10. The current market capitalization is approximately $220 million, an increase of $52.7 million compared to yesterday. Bio Protocol is a new financial layer in the field of DeSci (decentralized science) aimed at accelerating the commercialization of quality scientific projects. The protocol allows anyone to fund, develop, and manage tokenized scientific innovations from universities, companies, and researchers around the world. Bio Protocol supports promising research projects through low-cap crowdfunding sales and rises as community attention and scientific progress increase. Important news about BIO recently: 1️⃣

Gate News Bot news, on August 12, according to CoinMarketCap data, as of the time of writing, BIO (Bio Protocol) is currently priced at 0.13 USD, with a rise of 14.46% in the last 24 hours, reaching a high of 0.14 USD and a low of 0.06 USD. The current market capitalization is approximately 215 million USD, an increase of 27.2 million USD compared to yesterday. Bio Protocol is a new financial layer of DeSci (decentralized science) aimed at accelerating the commercialization of the best scientific achievements. This protocol allows anyone to fund, develop, and manage tokenized scientific innovations from universities, companies, and researchers around the world. The Bio ecosystem is driving biotechnology innovation, accelerating drug development through decentralized financing and coordination, shortening the development cycle from decades to months. Important news about BIO recently: 1️⃣ **Staking Power

Gate News Bot news, on August 08, according to CoinMarketCap data, as of the time of writing, BIO (Bio Protocol) is currently priced at 0.09 USD, having risen 48.96% in the last 24 hours, reaching a high of 0.10 USD and a low of 0.05 USD. The current market capitalization is approximately 150 million USD, an increase of 49.4 million USD compared to yesterday. Bio Protocol is a new financial layer of DeSci (Decentralized Science) aimed at accelerating the commercialization of the best scientific achievements. The protocol allows anyone to fund, develop, and manage tokenized scientific innovations from universities, companies, and researchers around the world. Bio Protocol supports promising research through low-capital fundraising and rises with community interest and scientific progress. Important news about BIO recently: 1️⃣ **Bio Prot

Gate News Bot news, August 1, according to CoinMarketCap data, as of the time of writing, BLZ (Bluzelle) is currently priced at $0.04, with a 17.22% rise in the last 24 hours, reaching a high of $0.05 and a low of $0.04. The current market capitalization is approximately $20.6 million, an increase of $3.03 million compared to yesterday. Bluzelle is a blockchain infrastructure project focused on decentralized science (DeSci). Its core mission is to empower global scientific research through blockchain technology, particularly in addressing major human challenges such as aging. Bluzelle provides a complete set of DeSci solutions, including the high-performance Bluzelle chain, the decentralized storage system R2 Storage, and NFTs for intellectual property tokenization.

The DeSci zone Token rebounded on May 14, with prices of RIF, URO, RSC, BIO, and VITA rising by 41.8%, 36.9%, 20.6%, 18.5%, and 17.4%, respectively.

MOBOX announced its entry into the DeSci field, launching a gamified research platform, with the first hardware product being the "魔盒" (MOB), supporting basic biological experiments. In the future, it will expand to medicinal plants, microorganisms, and build a global research collaboration platform to serve AI drug development, smart agriculture, and more.

PANews April 1 news, according to The Block, the decentralized research platform Bio Protocol has launched a V1 version upgrade, based on Base and Solana, with core features including the BioDAO Launchpad, AI-driven BioAgents, and a new DAO milestone mechanism. The new system has transitioned from the original screening accelerator to a fully on-chain project declaration and financing process, expanding the practical utility of BIO Token in governance, financing, and services, promoting the democratization of research in the DeSci field.

BlockBeats news, on March 25, according to GMGN market data, DeSci zone Tokens are rebounding, among which: BIO is currently priced at $0.1008, with a 24-hour rise of 16.26%; VITA is currently priced at $1.28, with a 24-hour rise of 10.2%; YNE is currently priced at $0.0188, with a 24-hour rise of 15.7%.

The Bio Protocol of DeSci project plans to create a Decentralization BioAgents team in 2025, using new biotechnological tools to accomplish scientific missions and integrate tokenomics. Each BioDAO will be equipped with coordinating agents to help scientists focus on research. BIOToken is key to incentivizing and managing the rise of the team, and external partner fees will be destroyed.

BlockBeats news, on February 23, according to official sources, ResearchHub has received a $2 million investment from Boost VC. It is reported that BoostVC is deepening its commitment to accelerating scientific research at ResearchHub. This funding will further strengthen ResearchHub's efforts to make research more open, transparent, and collaborative.

Pump Science introduces the concept of ISO (Initial Subscription Offering), where holders can lock in a 4% Airdrop share of the future launch of 20 new DeSci projects by donating Tokens, and all donation funds will be used for market making/marketing/listing promotion. The profits from the RODeo prediction market will be used for the repurchase and burning of rif and uro, without creating new Tokens.

Bio Protocol, DeSci AI, and Long COVID Labs are collaborating to accelerate research on the novel coronavirus (Long COVID) using proxy technology. The goal is to identify research errors, potential drug targets, and enhance research data accessibility. Long COVID Labs is auctioning COVID tokens, and the auction will end on January 17th at 23:00.

CoinWorld News, January 8th, BIO Protocol announced a strategic partnership with CRISPR AI to jointly promote the future development of Decentralization Science (DeSci). This cooperation includes the strategic allocation of Nuclease DAO to BIO Treasury, injecting new momentum into the collaboration between the two parties in the field of gene editing and distributed scientific research. This initiative will accelerate innovation in the DeSci field. In addition, the heavyweight project Long COVID Labs ($COVID) on the BIO Protocol platform will be exclusively launched on BIO Launchpad on January 9, 2025. The project is led by current and former researchers at Stanford University, aiming to accelerate the research progress of over 100 million long COVID patients worldwide through Decentralization financing.

On January 6th, according to Coin World News, Bio Protocol officially announced the launch of its latest BioDAO project in January 2025, including Quantum Biology DAO, Long Covid Labs, and Curetopia. These projects focus on key challenges in cutting-edge scientific fields and aim to accelerate breakthroughs using Decentralization Scientific Research Power (DeSci): - Quantum Biology DAO: dedicated to developing quantum microscopes to advance biological research, founded by Clarice D. Aiello, a quantum biology expert from the Massachusetts Institute of Technology (MIT), has successfully raised more than $6.8 million through the launch board and the TGE (Token Generation Event) is about to go online. - Long Covid

BlockBeats news, on January 4th, according to official sources, DeSci project Big Pharmai (DRUGS) announced the upcoming launch of a brand new biological agent framework.

BlockBeats news, on January 3, Ethereum co-founder Vitalik Buterin said on the Desci podcast that cryptocurrency is an efficient way to raise funds. It not only provides more diversified funding sources for DeSci, but also greatly improves the convenience of funding. He has a strong interest in longevity research and medical research, and has supported related projects through cryptocurrency, such as donating cryptocurrency to support India's anti-epidemic efforts and launching the Balvi epidemic prevention project. Vitalik looks forward to seeing more innovation in the DeSci field, such as: 1. Research contribution distribution mechanism, fair recognition of the value of research work; 2. Interdisciplinary public education fund; 3.

Odaily Planet Daily News According to BIOProtocol disclosed on the X platform, Vitalik Buterin, co-founder of Ethereum, in DeSci

BlockBeats News, on January 3rd, RSS officials stated that they are building the ultimate AI data framework to support functional AI agent innovation in the encryption space and are conducting in-depth research on on-chain applications.

BlockBeats news, on December 29th, according to GMGN data, the DeSci project Token Big Pharmai (DRUGS) broke through 0.03 US dollars, with a 24-hour increase of 51.2%, Market Cap now reports 3340

7:00-12:00 Keywords: Federal Reserve, Trump, BIO Protocol The probability of the Federal Reserve keeping interest rates unchanged in January next year is 91.4%. 2. Google releases its annual search trends, with Trump topping the list of personalities; 3. Pump Science: Only tokens in non-custodial wallets will be counted for airdrops; 4. The Japanese government has made an official response to the proposal to establish a Bitcoin reserve: it is still in the discussion stage; This year, 9 new Bitcoin ETFs and MicroStrategy in the United States have accumulated a total increase of over 1.1 million BTC; 6. The DeSci Protocol BIO Protocol initiates a community proposal to "cross-chain BIO to the Solana network";

ChainCatcher message, Decentralization science protocol BIO Protocol post that scientific funding will become one of the main use cases for the next period of Crypto Assets, and DeSci is happening before our eyes. Rare diseases are often overlooked by pharmaceutical companies, and this is a typical example. Curetopia (@endrarediseases) plans to launch a related project in early 2025. Earlier, Siqi Chen, founder and CEO of Runway, posted that funding rare disease research is a legitimate use case for Crypto Assets, and he stated that the funds raised through the meme coin $MIRA will be directly used for Hankinson.